Profile data is unavailable for this security.
About the company
The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
- Revenue in HKD (TTM)15.30bn
- Net income in HKD3.18bn
- Incorporated--
- Employees15.00k
- LocationUnited Laboratories International Holdings Ltd6 FuK Wang StreetYuen Long Industrial EstateYuen Long Hong KongHKG
- Phone+852 26871033
- Fax+852 26871031
- Websitehttp://www.tul.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Everest Medicines Ltd | 457.20m | -1.15bn | 10.25bn | 520.00 | -- | 2.10 | -- | 22.42 | -3.57 | -3.57 | 1.42 | 15.02 | 0.0756 | 5.23 | 3.22 | 1,058,327.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Luye Pharma Group Ltd | 6.90bn | 841.60m | 10.50bn | 5.23k | 12.47 | 0.738 | 6.20 | 1.52 | 0.2237 | 0.2237 | 1.83 | 3.78 | 0.236 | 2.44 | 3.02 | 1,308,626.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SSY Group Ltd | 6.47bn | 1.37bn | 11.15bn | 5.80k | 8.21 | 1.54 | 6.10 | 1.72 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| Shanghai Henlius Biotech Inc | 6.16bn | 756.26m | 11.82bn | 3.55k | 15.67 | 4.20 | 10.19 | 1.92 | 1.39 | 1.39 | 11.29 | 5.18 | 0.5764 | 1.90 | 6.82 | 1,694,066.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| China Traditional Chinese Med Hldg CoLtd | 18.79bn | 1.00bn | 11.99bn | 17.72k | 11.96 | 0.5134 | 5.24 | 0.6378 | 0.199 | 0.199 | 3.73 | 4.64 | 0.453 | 1.54 | 1.82 | 1,086,100.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
| 3SBio Inc | 9.20bn | 1.81bn | 13.97bn | 5.61k | 7.84 | 0.8889 | 6.21 | 1.52 | 0.7437 | 0.7437 | 3.78 | 6.56 | 0.3575 | 1.52 | 6.87 | 1,700,070.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Grand Pharmaceutical Group Ltd | 10.59bn | 2.41bn | 16.19bn | 10.78k | 6.62 | 1.03 | 5.63 | 1.53 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 4.54 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| Simcere Pharmaceutical Group Ltd | 6.93bn | -1.21bn | 17.74bn | 6.41k | -- | 2.37 | -- | 2.56 | -0.4604 | -0.4604 | 2.69 | 2.97 | 0.5198 | 2.19 | 2.64 | 985,844.90 | -9.04 | 10.17 | -11.71 | 15.60 | 77.02 | 78.82 | -17.40 | 17.50 | 1.88 | 0.4721 | 0.1461 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
| China Medical System Holdings Ltd | 7.66bn | 1.52bn | 19.00bn | 5.78k | 12.53 | 1.08 | 10.79 | 2.48 | 0.6216 | 0.6216 | 3.13 | 7.19 | 0.384 | 2.89 | 5.65 | 1,343,944.00 | 7.51 | 18.44 | 8.53 | 21.14 | 74.13 | 75.47 | 19.56 | 34.26 | 3.97 | -- | 0.0667 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| The United Laboratories Intl. Hldgs Ltd. | 15.30bn | 3.18bn | 19.19bn | 15.00k | 6.04 | 1.30 | 5.05 | 1.25 | 1.75 | 1.75 | 8.42 | 8.13 | 0.6578 | 3.30 | 5.67 | 1,020,171.00 | 13.65 | 7.89 | 20.72 | 12.64 | 46.15 | 44.17 | 20.75 | 12.73 | 1.72 | -- | 0.1532 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
| Zai Lab Ltd | 2.51bn | -2.32bn | 23.81bn | 2.18k | -- | 4.29 | -- | 9.49 | -2.39 | -2.39 | 2.58 | 5.58 | 0.3083 | 3.04 | 5.52 | -- | -28.50 | -37.72 | -34.92 | -42.72 | 63.17 | 64.75 | -92.44 | -282.44 | 3.29 | -- | 0.0908 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
| HUTCHMED (China) Ltd | 4.75bn | -326.19m | 24.75bn | 1.97k | -- | 4.30 | -- | 5.21 | -0.3881 | -0.3881 | 5.50 | 6.60 | 0.4775 | 7.10 | 4.15 | 2,387,889.00 | -3.30 | -14.35 | -4.65 | -20.43 | 41.67 | 36.57 | -6.91 | -31.44 | 2.68 | -- | 0.0984 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
| WuXi XDC Cayman Inc | 3.05bn | 649.44m | 27.71bn | 1.50k | 43.29 | 4.23 | 37.46 | 9.07 | 0.5336 | 0.5336 | 2.70 | 5.46 | 0.5586 | 21.31 | 2.85 | 2,592,253.00 | 11.88 | -- | 15.43 | -- | 30.96 | -- | 21.27 | -- | 4.02 | -- | 0.0113 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
Data as of Nov 01 2024. Currency figures normalised to United Laboratories International Holdings Ltd's reporting currency: Hong Kong Dollar HKD
8.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 33.94m | 1.87% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 28.82m | 1.59% |
| American Century Investment Management, Inc.as of 03 Oct 2024 | 16.05m | 0.88% |
| Goldman Sachs Asset Management LPas of 24 Oct 2024 | 15.91m | 0.88% |
| Victory Capital Management, Inc. (Investment Management)as of 30 Jun 2024 | 13.96m | 0.77% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 11.37m | 0.63% |
| Allianz Global Investors GmbHas of 30 Jun 2024 | 10.81m | 0.60% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 10.74m | 0.59% |
| Bessemer Investment Management LLCas of 31 Jul 2024 | 7.27m | 0.40% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 6.49m | 0.36% |
More ▼
Data from 30 Jun 2024 - 23 Oct 2024Source: FactSet Research Systems Inc.
